Efficacy and safety of ipragliflozin as an add ‐on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: a randomized controlled trial

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - June 4, 2018 Category: Endocrinology Authors: Kyung ‐Ah Han , Suk Chon , Choon Hee Chung , Soo Lim , Kwan‐Woo Lee , SeiHyun Baik , Chang Hee Jung , Dong‐Sun Kim , Kyong Soo Park , Kun‐Ho Yoon , In‐Kyu Lee , Bong‐Soo Cha , Taishi Sakatani Source Type: research